Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Training local Karen and Burman women as skilled birth attendants in refugee settings resulted in no adverse perinatal outcomes and many positive outcomes such as a drop in stillbirths and infant deaths and more babies being born in clinics rather than at home, says a new study published in the scientific journal PLOS ONE.

Nurses attending Birth attendant training

11 October 2016, Mae Sot (Thailand) – Training local Karen and Burman women as skilled birth attendants in refugee settings resulted in no adverse perinatal outcomes and many positive outcomes such as a drop in stillbirths and infant deaths and more babies being born in clinics rather than at home, says a new study published in the scientific journal PLOS ONE. 

Developed on the Thai-Myanmar border, the training programme may be a model that could be used in poor, remote or conflict-affected communities around the world, experts say.

“This is a prime example of helping to reduce perinatal mortality and maintain low rates of maternal mortality in childbirth in a very disadvantaged population. This model could be translated to other low-resource, low-income settings,” said Stephen Kennedy, Professor of Reproductive Medicine, University of Oxford, UK.

The study examined more than 15,000 births from 2008-2015, after the Shoklo Malaria Research Unit (SMRU) had begun giving accelerated skilled birth attendant training to provide safe maternity care when faced with a shortage of qualified midwives in its clinics on the Thai-Myanmar border. 

The training to migrant and refugee Karen and Burman women living in north-western Thailand near the Myanmar border resulted in no adverse perinatal outcomes and many positive outcomes such as a reduction in stillbirths and neonatal deaths, a 25% increase in clinic births, a 16.4% drop in the use of episotomies and 99% use of a partogram (a composite record of key maternal and fetal data) during labour.

In South-East Asia fewer than half of women giving birth have access to a skilled birth attendant, according to UN figures. Most maternal deaths and disability are preventable if the woman has access to care from a skilled birth attendant.

Faced with a predicted shortage of skilled birth attendants at Maela, the largest refugee camp on the Thai-Myanmar border, in 2008 the Shoklo Malaria Research Unit (SMRU) invited a registered midwife to develop a six-month, locally adapted skilled birth attendants curriculum using core guidelines from the International Confederation of Midwives (ICM), the International Federation of Obstetricians and Gynaecologists (FIGO) and the WHO.

“There is a shortage of qualified midwives worldwide and midwives and skilled birth attendants can play a central role in reducing maternal and new-born mortality and morbidity, particularly in neglected populations and resource-limited settings,” said Ms Adrienne White, the study’s author.

“In refugee settings, areas of conflict or where national systems have collapsed, evidence-based skilled birth attendant training adapted to local conditions should be accelerated to provide immediate care to vulnerable populations and ensure the continuation of practices that foster normal labour and birth,” said Ms. White.

A unit of the Bangkok-based Mahidol Oxford Tropical Medicine Research Unit (MORU), SMRU is based in the refugee camps and migrant communities along the Thai-Myanmar border. The five SMRU clinics have provided free, basic humanitarian care to refugees since 1986 and in migrant communities since 1998.

“Pregnant women and new-borns are very vulnerable so a safe level of basic and emergency obstetric and new-born care is imperative,” said Oxford Prof Rose McGready, Deputy Director of SMRU. “Many countries are struggling to provide safe birth care. To bridge this gap we must trust and develop local people’s skills. This study should help international authorities and NGOs, and national health programmes in resource-limited settings consider their recommendations and training for birthing services.”

Led by researchers at the Shoklo Malaria Research Unit (SMRU) in Thailand, and the Midwifery Research and Education Unit, Hannover Medical School, Germany, among others, the study was funded by the Wellcome Trust (UK), StichtingMalariadokters (The Netherlands) and the Australian Volunteers for International Development (AVID).

Notes for editors

The Mahidol-Oxford Tropical Medicine Research Unit (MORU), www.tropmedres.ac,  is a research collaboration between Mahidol University in Thailand and Oxford University and the Wellcome Trust in the UK.  A unit of the Mahidol Oxford Tropical Medicine Research Unit (MORU), the Shoklo Malaria Research Unit (SMRU) is based in Mae Sot, Thailand, and works in the refugee camps and migrant communities along the Thai-Myanmar border.

Reference:

White AL, Min TH, Gross MM, Kajeechiwa L, Thwin MM, Hanboonkunupakarn B, Than HH, Zin TW, Rijken MJ, Hoogenboom G, McGready R, Accelerated Training of Skilled Birth Attendants in a Marginalized Population on the Thai-Myanmar Border: A Multiple Methods Program Evaluation, PLoS ONE 11(10): e0164363. doi:10.1371/journal.pone.0164363.

Similar stories

Ruam Thai Phatthana 2 Clinic Officially Opens in Phop Phra District

The Ruam Thai Phatthana 2 (RTS) Clinic was officially opened on 24 September 2026 in Ruam Thai Subdistrict, Phop Phra District, Tak Province, marking a new chapter in healthcare services for communities along the Thailand–Myanmar border.

Francois Nosten on Fever Pitch podcast, on a collapsing border where medicine meets war

Professor Francois Nosten, Director of MORU's Shoklo Malaria Research Unit (SMRU), reflects on the decades he’s spent on the border between Thailand and Myanmar, a place of relentless upheaval and quiet endurance. From the 1980s onward, he has lived amid war, displacement, and disease, building a fragile bridge between science and survival. He characterizes the border as a wound that never quite closes – people cross not for opportunity but to escape a state that devours its own. What he describes is not steady progress but a cycle of collapse and recovery, every advance shadowed by the return of violence and the onset of disease.

SMRU’s ‘TB Village’: A lifeline for marginalised patients on the Thai–Myanmar border

In a settlement of bamboo cabins, among mango and jackfruit trees, the Shoklo Malaria Research Unit runs a secluded clinic known as 'TB Village.' Reachable only by dirt roads, this sanctuary provides critical treatment and quarantine for dozens of marginalized Burmese tuberculosis patients. Here, at SMRU, patients receive care for diseases like tuberculosis and malaria. The unit works to heal patients and prevent outbreaks from crossing borders, providing a lifeline of safety.

Research Spotlight: The IRONMUM Trial at SMRU

IRONMUM is one example of SMRU’s long-standing collaboration with global partners to address critical health challenges in low- and middle-income settings. Through partnerships with institutions such as the University of Oxford and the Mahidol Oxford Tropical Medicine Research Unit (MORU), SMRU conducts research that is firmly grounded in local realities, ensuring that preventive strategies and treatments are effective where they are needed most. Working on the Thailand–Myanmar border since 1986, SMRU combines research, clinical care, and humanitarian action to improve the health of mothers, children, and vulnerable populations affected by infectious diseases and limited access to healthcare.

Analysis of SMRU samples could lead to vaccine for multiple childhood infections

The first large-scale genomic exploration of H. influenzae, a bacteria that causes 200m infections per year in children worldwide, has revealed extensive antibiotic resistance and uncovered genetic clues that could help in future vaccine development, say researchers from Wellcome Sanger Institute, the Universities of Oxford and Oslo, and MORU’s Shoklo Malaria Research Unit (SMRU) and Cambodia-Oxford Medical Research Unit (COMRU).

Rose McGready honoured for her work to improve healthcare for Thai-Myanmar border communities

On 17 Nov at a ceremony in Canberra, Prof Rose McGready, Deputy Director of the Shoklo Malaria Research Unit (SMRU), was honoured with the 2026 ACT Australian of the Year Award for her extraordinary dedication over 30 years to improving healthcare for displaced and marginalised communities along the Thai-Myanmar border which, coupled with clinical and research work that has changed the treatment of malaria around the world, particularly for pregnant and breastfeeding women, has saved the lives of countless mothers and their babies.

Similar stories

Ruam Thai Phatthana 2 Clinic Officially Opens in Phop Phra District

The Ruam Thai Phatthana 2 (RTS) Clinic was officially opened on 24 September 2026 in Ruam Thai Subdistrict, Phop Phra District, Tak Province, marking a new chapter in healthcare services for communities along the Thailand–Myanmar border.

Francois Nosten on Fever Pitch podcast, on a collapsing border where medicine meets war

Professor Francois Nosten, Director of MORU's Shoklo Malaria Research Unit (SMRU), reflects on the decades he’s spent on the border between Thailand and Myanmar, a place of relentless upheaval and quiet endurance. From the 1980s onward, he has lived amid war, displacement, and disease, building a fragile bridge between science and survival. He characterizes the border as a wound that never quite closes – people cross not for opportunity but to escape a state that devours its own. What he describes is not steady progress but a cycle of collapse and recovery, every advance shadowed by the return of violence and the onset of disease.

SMRU’s ‘TB Village’: A lifeline for marginalised patients on the Thai–Myanmar border

In a settlement of bamboo cabins, among mango and jackfruit trees, the Shoklo Malaria Research Unit runs a secluded clinic known as 'TB Village.' Reachable only by dirt roads, this sanctuary provides critical treatment and quarantine for dozens of marginalized Burmese tuberculosis patients. Here, at SMRU, patients receive care for diseases like tuberculosis and malaria. The unit works to heal patients and prevent outbreaks from crossing borders, providing a lifeline of safety.

Research Spotlight: The IRONMUM Trial at SMRU

IRONMUM is one example of SMRU’s long-standing collaboration with global partners to address critical health challenges in low- and middle-income settings. Through partnerships with institutions such as the University of Oxford and the Mahidol Oxford Tropical Medicine Research Unit (MORU), SMRU conducts research that is firmly grounded in local realities, ensuring that preventive strategies and treatments are effective where they are needed most. Working on the Thailand–Myanmar border since 1986, SMRU combines research, clinical care, and humanitarian action to improve the health of mothers, children, and vulnerable populations affected by infectious diseases and limited access to healthcare.

Analysis of SMRU samples could lead to vaccine for multiple childhood infections

The first large-scale genomic exploration of H. influenzae, a bacteria that causes 200m infections per year in children worldwide, has revealed extensive antibiotic resistance and uncovered genetic clues that could help in future vaccine development, say researchers from Wellcome Sanger Institute, the Universities of Oxford and Oslo, and MORU’s Shoklo Malaria Research Unit (SMRU) and Cambodia-Oxford Medical Research Unit (COMRU).

Rose McGready honoured for her work to improve healthcare for Thai-Myanmar border communities

On 17 Nov at a ceremony in Canberra, Prof Rose McGready, Deputy Director of the Shoklo Malaria Research Unit (SMRU), was honoured with the 2026 ACT Australian of the Year Award for her extraordinary dedication over 30 years to improving healthcare for displaced and marginalised communities along the Thai-Myanmar border which, coupled with clinical and research work that has changed the treatment of malaria around the world, particularly for pregnant and breastfeeding women, has saved the lives of countless mothers and their babies.